Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

January 31, 2009

Conditions
Parkinson's Disease
Interventions
DRUG

Cabergoline

DRUG

Levodopa

Trial Locations (2)

01307

Department of Neurology at the Technical University of Dresden, Dresden

Department of Nuclear Medicine at the Technical University of Dresden, Dresden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Technische Universität Dresden

OTHER